CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-15 | Megna Michael R CHIEF ACCOUNTING OFFICER | Grant or award 10b5-1 | +279 | $33.50 | $9K | 27,697 |
| 2026-07-01 | Malkani Dhiraj H CHIEF STRATEGY OFFICER | Grant or award · Share Option | +82,600 | 0 | ||
| 2026-07-01 | Malkani Dhiraj H CHIEF STRATEGY OFFICER | Grant or award · Restricted Share Unit | +14,000 | 0 | ||
| 2026-07-01 | Malkani Dhiraj H CHIEF STRATEGY OFFICER | Grant or award · Performance Share Option | +2,119 | 0 | ||
| 2026-07-01 | Malkani Dhiraj H CHIEF STRATEGY OFFICER | Grant or award · Performance Share Option | +2,188 | 0 | ||
| 2026-07-01 | Malkani Dhiraj H CHIEF STRATEGY OFFICER | Grant or award · Performance Share Unit | +1,245 | 0 | ||
| 2026-07-01 | Malkani Dhiraj H CHIEF STRATEGY OFFICER | Grant or award · Performance Share Unit | +1,307 | 0 | ||
| 2026-06-01 | Patel Sanj K CHAIRMAN & CEO | Conversion | +900,000 | 951,794 | ||
| 2026-06-01 | Patel Sanj K CHAIRMAN & CEO | Conversion · Class B Ordinary Shares | −900,000 | 626,160 | ||
| 2026-05-29 | McCain Tracey L Director | Option exercise | +2,799 | 15,345 | ||
| 2026-05-29 | McCain Tracey L Director | Grant or award · Share Option | +12,158 | 12,158 | ||
| 2026-05-29 | McCain Tracey L Director | Grant or award · Restricted Share Units | +2,026 | 2,026 | ||
| 2026-05-29 | McCain Tracey L Director | Option exercise · Restricted Share Units | −2,799 | 0 | ||
| 2026-05-29 | Levy Richard S Director | Option exercise | +2,799 | 21,956 | ||
| 2026-05-29 | Levy Richard S Director | Grant or award · Share Option | +12,158 | 12,158 | ||
| 2026-05-29 | Levy Richard S Director | Grant or award · Restricted Share Units | +2,026 | 2,026 | ||
| 2026-05-29 | Levy Richard S Director | Option exercise · Restricted Share Units | −2,799 | 0 | ||
| 2026-05-29 | Malley Thomas Director | Option exercise | +2,799 | 15,345 | ||
| 2026-05-29 | Malley Thomas Director | Grant or award · Share Option | +12,158 | 12,158 | ||
| 2026-05-29 | Malley Thomas Director | Grant or award · Restricted Share Units | +2,026 | 2,026 |
Page 10 of 74 · 1,467 trades